Hemodialysis Is Associated With Increased Peripheral Artery Occlusive Disease Risk Among Patients With End-Stage Renal Disease A Nationwide Population-Based Cohort Study

被引:19
作者
Lin, Chin-Sheng [1 ]
Chen, Sy-Jou [2 ]
Sung, Chih-Chien [3 ]
Lin, Cheng-Li [4 ,5 ]
Lin, Shih-Hua [3 ]
Cheng, Shu-Meng [1 ]
Wang, I-Kuan [6 ,7 ,8 ,9 ]
Huang, Wen-Sheng [10 ]
Kao, Chia-Hung [6 ,7 ,11 ,12 ]
机构
[1] Natl Def Med Ctr, Triserv Gen Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[2] Natl Def Med Ctr, Dept Emergency Med, Triserv Gen Hosp, Taipei, Taiwan
[3] Natl Def Med Ctr, Div Nephrol, Dept Med, Triserv Gen Hosp, Taipei, Taiwan
[4] China Med Univ, China Med Univ Hosp, Management Off Hlth Data, Taichung 404, Taiwan
[5] China Med Univ, Coll Med, Taichung 404, Taiwan
[6] China Med Univ, Grad Inst Clin Med Sci, Taichung 404, Taiwan
[7] China Med Univ, Sch Med, Taichung 404, Taiwan
[8] China Med Univ, Dept Internal Med, Coll Med, Taichung 404, Taiwan
[9] China Med Univ Hosp, Div Kidney Dis, Taichung, Taiwan
[10] Changhua Christian Hosp, Dept Nucl Med, Changhua, Taiwan
[11] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan
[12] China Med Univ Hosp, PET Ctr, Taichung, Taiwan
关键词
HIGH-DENSITY-LIPOPROTEIN; ANKLE-BRACHIAL INDEX; C-REACTIVE PROTEIN; VASCULAR-DISEASE; PERITONEAL-DIALYSIS; THERAPY; CELLS; CALCIFICATION; INFLAMMATION; DYSFUNCTION;
D O I
10.1097/MD.0000000000001164
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To investigate the effect of different dialysis modalities on the incidence of peripheral artery occlusive disease (PAOD) among patients with end-stage renal disease (ESRD) in a large population-based cohort study.The cohort study included 26,927 ESRD patients who underwent hemodialysis (17,737 patients, hemodialysis [HD] cohort) or peritoneal dialysis (PD, 9190 patients, PD cohort), and 107,588 matched controls between 2000 and 2010. A Cox proportional hazards model was to evaluate the risk of PAOD in the ESRD underwent HD or PD.Based on a mean follow-up period of 2.92, 3.64, and 4.91 years in the PD, HD, and control cohorts, respectively, the incidences of PAOD were 18.1% and 8.10% higher in the HD and PD cohorts, respectively, compared with the control cohort (log-rank test P<0.001). The patients who underwent HD or PD exhibited a higher risk of PAOD compared with the control cohort regardless of age, sex, and presence or absence of comorbidities. In addition, the incidence of PAOD in the PD cohort and the propensity score-matched HD cohort were 12.4 and 20.7 per 1000 person-years, respectively, with a hazard ratio of 1.92 (95% confidence interval=1.62-2.28) in HD patients, compared with the PD cohort.This nationwide population-based cohort study suggested a significantly increased risk of PAOD among ESRD patients. Moreover, the PD patients have a lower risk of developing PAOD compared with the HD cohort, indicating the beneficial roles of PD in reducing PAOD risk in ESRD patients.
引用
收藏
页数:7
相关论文
共 33 条
[11]   The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremia [J].
Himmelfarb, J ;
Stenvinkel, P ;
Ikizler, TA ;
Hakim, RM .
KIDNEY INTERNATIONAL, 2002, 62 (05) :1524-1538
[12]   Treatment of peripheral arterial disease - Extending "intervention'' to "therapeutic choice'' [J].
Hirsch, AT .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (18) :1944-1947
[13]   High-density lipoprotein in uremic patients: metabolism, impairment, and therapy [J].
Khoueiry, Georges ;
Abdallah, Mokhtar ;
Saiful, Faisal ;
Rafeh, Nidal Abi ;
Raza, Muhammad ;
Bhat, Tariq ;
El-Sayegh, Suzanne ;
Kalantar-Zadeh, Kamyar ;
Lafferty, James .
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2014, 46 (01) :27-39
[14]   Peripheral artery disease in peritoneal dialysis and hemodialysis patients: single-center retrospective study in Taiwan [J].
Lee, Chun-Chuan ;
Wu, Chih-Jen ;
Chou, Li-Hua ;
Shen, Su-Mei ;
Chiang, Sheng-Fang ;
Jen, Pi-Chu ;
Yeh, Mei-Ching ;
Pan, Chi-Feng .
BMC NEPHROLOGY, 2012, 13
[15]   Enhanced expression of glucose transporter-1 in vascular smooth muscle cells via the Akt/tuberous sclerosis complex subunit 2 (TSC2)/mammalian target of rapamycin (mTOR)/ribosomal S6 protein kinase (S6K) pathway in experimental renal failure [J].
Lin, Chih-Yuan ;
Hsu, Shih-Che ;
Lee, Herng-Sheng ;
Lin, Shih-Hua ;
Tsai, Chien-Sung ;
Huang, Shih-Ming ;
Shih, Chun-Che ;
Hsu, Yu-Juei .
JOURNAL OF VASCULAR SURGERY, 2013, 57 (02) :475-485
[16]   Ankle-Brachial Index and Bone Turnover in Patients on Dialysis [J].
London, Gerard M. ;
Marchais, Sylvain J. ;
Guerin, Alain P. ;
de Vernejoul, Marie-Christine .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 26 (02) :476-483
[17]   Determinants of arterial wall stiffness and peripheral artery occlusive disease in nondiabetic hemodialysis patients [J].
Matsumae, Tomoji ;
Abe, Yasuhiro ;
Murakami, Genji ;
Ishihara, Motoichi ;
Ueda, Kazuo ;
Saito, Takao .
HYPERTENSION RESEARCH, 2007, 30 (05) :377-385
[18]   Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes [J].
Memoli, B ;
Minutolo, R ;
Bisesti, V ;
Postiglione, L ;
Conti, A ;
Marzano, L ;
Capuano, A ;
Andreucci, M ;
Balletta, MM ;
Guida, B ;
Tetta, C .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (02) :266-273
[19]   Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease [J].
Moore, Kathryn J. ;
Fisher, Edward A. .
IMMUNITY, 2013, 38 (04) :628-630
[20]   Expanded CD14+ CD16+ monocyte subpopulation in patients with acute and chronic infections undergoing hemodialysis [J].
Nockher, WA ;
Scherberich, JE .
INFECTION AND IMMUNITY, 1998, 66 (06) :2782-2790